awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q92973368-EA32E01D-3EC6-4F08-841F-3EADBBBDA494
Q92973368-EA32E01D-3EC6-4F08-841F-3EADBBBDA494
BestRank
Statement
http://www.wikidata.org/entity/statement/Q92973368-EA32E01D-3EC6-4F08-841F-3EADBBBDA494
A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC
P50
Q92973368-EA32E01D-3EC6-4F08-841F-3EADBBBDA494
BestRank
Statement
http://www.wikidata.org/entity/statement/Q92973368-EA32E01D-3EC6-4F08-841F-3EADBBBDA494
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afd886cad0ab8394776fa48c63c6a332d2cb0968
P1545
11
http://www.w3.org/2001/XMLSchema#string
P50
You Lu